|
市場調査レポート
商品コード
1667640
低線量率小線源治療の世界市場:規模、シェア、動向分析(2025年~2031年):MedCoreLow-Dose Radiation Brachytherapy Market Size, Share & Trend Analysis | Global | 2025-2031 | MedCore | Includes: LDR Needle Market and LDR Brachytherapy Iodine Seed Market |
||||||
適宜更新あり
|
|||||||
| 低線量率小線源治療の世界市場:規模、シェア、動向分析(2025年~2031年):MedCore |
|
出版日: 2024年12月11日
発行: iData Research Inc.
ページ情報: 英文 164 Pages
納期: 即日から翌営業日
|
全表示
- 概要
- 図表
- 目次
世界の低線量率小線源治療(LDRB)の市場規模は、2024年に1億200万米ドルとなりました。同市場は、2.2%のCAGRで拡大し、2031年には1億1,900万米ドルに達すると予測されています。
放射線外部照射(EBRT)に対する小線源治療の有効性に関する調査が続いており、LDRBソリューションに対する需要が安定しています。前立腺がん、肺がん、膵臓がん、頭頸部がんなど、さまざまながん種に使用されています。X線透視法と超音波画像の改良により、より良い臨床結果を得るための針留めの精度が向上しています。
当レポートでは、世界の低線量率小線源治療市場について調査し、市場の概要とともに、セグメント別、地域別動向、競合情勢などを提供しています。
目次
低線量率小線源治療市場
- エグゼクティブサマリー
- イントロダクション
- 手技件数
- 開腹前立腺切除術
- 腹腔鏡下前立腺摘出術
- ロボットによる前立腺切除術
- 待機療法
- HIFU手技
- 近接放射線療法
- 高線量放射線治療
- 外部放射線治療(一次)
- 外部放射線治療(二次)
- 市場分析と予測
- LDRニードル市場
- LDR近接放射線療法用ヨウ素シード市場
- 促進要因と抑制要因
- 競合市場シェア分析
LIST OF CHARTS
List of Charts
- Chart 10-1: Low-Dose Radiation Brachytherapy Market, Global, 2024 - 2031
- Chart 10-2: Low-Dose Radiation Brachytherapy Market, Global, 2024
- Chart 10-3: Prostate Cancer Procedures by Region, Global, 2021 - 2031
- Chart 10-4: Low-Dose Radiation Brachytherapy Market by Segment, Global, 2021 - 2031
- Chart 10-5: Low-Dose Radiation Brachytherapy Market by Region, Global, 2021 - 2031
- Chart 10-6: Leading Competitors, Low-Dose Radiation Brachytherapy Market, Global, 2024
LIST OF FIGURES
List of Figures
- Figure 10-1: Low-Dose Radiation Brachytherapy Device Market Segmentation
- Figure 10-2: Low-Dose Radiation Brachytherapy Market Regions Covered, Global (1 of 2)
- Figure 10-3: Low-Dose Radiation Brachytherapy Market Regions Covered, Global (2 of 2)
- Figure 10-4: Prostate Cancer Procedures by Type, Global, 2021 - 2031 (1 of 2)
- Figure 10-5: Prostate Cancer Procedures by Type, Global, 2021 - 2031 (2 of 2)
- Figure 10-6: Prostate Cancer Procedures by Region, Global, 2021 - 2031
- Figure 10-7: Prostate Cancer Procedures by Country, North America, 2021 - 2031
- Figure 10-8: Prostate Cancer Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-9: Prostate Cancer Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-10: Prostate Cancer Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-11: Prostate Cancer Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-12: Prostate Cancer Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-13: Prostate Cancer Procedures by Country, Middle East, 2021 - 2031
- Figure 10-14: Prostate Cancer Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-15: Prostate Cancer Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-16: Prostate Cancer Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-17: Prostate Cancer Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-18: Prostate Cancer Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-19: Open Prostatectomy Procedures by Region, Global, 2021 - 2031
- Figure 10-20: Open Prostatectomy Procedures by Country, North America, 2021 - 2031
- Figure 10-21: Open Prostatectomy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-22: Open Prostatectomy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-23: Open Prostatectomy Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-24: Open Prostatectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-25: Open Prostatectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-26: Open Prostatectomy Procedures by Country, Middle East, 2021 - 2031
- Figure 10-27: Open Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-28: Open Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-29: Open Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-30: Open Prostatectomy Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-31: Open Prostatectomy Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-32: Laparoscopic Prostatectomy Procedures by Region, Global, 2021 - 2031
- Figure 10-33: Laparoscopic Prostatectomy Procedures by Country, North America, 2021 - 2031
- Figure 10-34: Laparoscopic Prostatectomy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-35: Laparoscopic Prostatectomy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-36: Laparoscopic Prostatectomy Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-37: Laparoscopic Prostatectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-38: Laparoscopic Prostatectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-39: Laparoscopic Prostatectomy Procedures by Country, Middle East, 2021 - 2031
- Figure 10-40: Laparoscopic Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-41: Laparoscopic Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-42: Laparoscopic Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-43: Laparoscopic Prostatectomy Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-44: Laparoscopic Prostatectomy Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-45: Robotic Prostatectomy Procedures by Region, Global, 2021 - 2031
- Figure 10-46: Robotic Prostatectomy Procedures by Country, North America, 2021 - 2031
- Figure 10-47: Robotic Prostatectomy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-48: Robotic Prostatectomy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-49: Robotic Prostatectomy Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-50: Robotic Prostatectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-51: Robotic Prostatectomy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-52: Robotic Prostatectomy Procedures by Country, Middle East, 2021 - 2031
- Figure 10-53: Robotic Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-54: Robotic Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-55: Robotic Prostatectomy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-56: Robotic Prostatectomy Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-57: Robotic Prostatectomy Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-58: Watchful Waiting Procedures by Region, Global, 2021 - 2031
- Figure 10-59: Watchful Waiting Procedures by Country, North America, 2021 - 2031
- Figure 10-60: Watchful Waiting Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-61: Watchful Waiting Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-62: Watchful Waiting Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-63: Watchful Waiting Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-64: Watchful Waiting Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-65: Watchful Waiting Procedures by Country, Middle East, 2021 - 2031
- Figure 10-66: Watchful Waiting Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-67: Watchful Waiting Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-68: Watchful Waiting Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-69: Watchful Waiting Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-70: Watchful Waiting Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-71: HIFU Procedures by Region, Global, 2021 - 2031
- Figure 10-72: HIFU Procedures by Country, North America, 2021 - 2031
- Figure 10-73: HIFU Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-74: HIFU Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-75: HIFU Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-76: HIFU Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-77: HIFU Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-78: HIFU Procedures by Country, Middle East, 2021 - 2031
- Figure 10-79: HIFU Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-80: HIFU Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-81: HIFU Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-82: HIFU Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-83: HIFU Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-84: Brachytherapy Procedures by Region, Global, 2021 - 2031
- Figure 10-85: Brachytherapy Sling Procedures by Country, North America, 2021 - 2031
- Figure 10-86: Brachytherapy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-87: Brachytherapy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-88: Brachytherapy Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-89: Brachytherapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-90: Brachytherapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-91: Brachytherapy Procedures by Country, Middle East, 2021 - 2031
- Figure 10-92: Brachytherapy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-93: Brachytherapy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-94: Brachytherapy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-95: Brachytherapy Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-96: Brachytherapy Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-97: High-Dose Radiation Procedures by Region, Global, 2021 - 2031
- Figure 10-98: High-Dose Radiation Procedures by Country, North America, 2021 - 2031
- Figure 10-99: High-Dose Radiation Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-100: High-Dose Radiation Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-101: High-Dose Radiation Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-102: High-Dose Radiation Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-103: High-Dose Radiation Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-104: High-Dose Radiation Procedures by Country, Middle East, 2021 - 2031
- Figure 10-105: High-Dose Radiation Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-106: High-Dose Radiation Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-107: High-Dose Radiation Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-108: High-Dose Radiation Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-109: High-Dose Radiation Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-110: External Radiation Therapy (Primary) Procedures by Region, Global, 2021 - 2031
- Figure 10-111: External Radiation Therapy (Primary) Procedures by Country, North America, 2021 - 2031
- Figure 10-112: External Radiation Therapy (Primary) Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-113: External Radiation Therapy (Primary) Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-114: External Radiation Therapy (Primary) Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-115: External Radiation Therapy (Primary) Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-116: External Radiation Therapy (Primary) Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-117: External Radiation Therapy (Primary) Procedures by Country, Middle East, 2021 - 2031
- Figure 10-118: External Radiation Therapy (Primary) Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-119: External Radiation Therapy (Primary) Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-120: External Radiation Therapy (Primary) Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-121: External Radiation Therapy (Primary) Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-122: External Radiation Therapy (Primary) Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-123: External Radiation Therapy (Secondary) Procedures by Region, Global, 2021 - 2031
- Figure 10-124: External Radiation Therapy (Secondary) Procedures by Country, North America, 2021 - 2031
- Figure 10-125: External Radiation Therapy (Secondary) Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
- Figure 10-126: External Radiation Therapy (Secondary) Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
- Figure 10-127: External Radiation Therapy (Secondary) Procedures by Country, Western Europe, 2021 - 2031
- Figure 10-128: External Radiation Therapy (Secondary) Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
- Figure 10-129: External Radiation Therapy (Secondary) Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
- Figure 10-130: External Radiation Therapy (Secondary) Procedures by Country, Middle East, 2021 - 2031
- Figure 10-131: External Radiation Therapy (Secondary) Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
- Figure 10-132: External Radiation Therapy (Secondary) Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
- Figure 10-133: External Radiation Therapy (Secondary) Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
- Figure 10-134: External Radiation Therapy (Secondary) Procedures by Country, Africa, 2021 - 2031 (1 of 2)
- Figure 10-135: External Radiation Therapy (Secondary) Procedures by Country, Africa, 2021 - 2031 (2 of 2)
- Figure 10-136: LDR Brachytherapy Device Market by Segment, Global, 2021 - 2031 (US$M)
- Figure 10-137: Market Value by Region, Low-Dose Radiation Brachytherapy Market, Global, 2021 - 2031 (US$M)
- Figure 10-138: LDR Needle Market, Global, 2021 - 2031
- Figure 10-139: Units Sold by Region, LDR Needle Market, Global, 2021 - 2031
- Figure 10-140: Average Selling Price by Region, LDR Needle Market, Global, 2021 - 2031 (US$)
- Figure 10-141: Market Value by Region, LDR Needle Market, Global, 2021 - 2031 (US$M)
- Figure 10-142: LDR Brachytherapy Iodine Seed Market, Global, 2021 - 2031
- Figure 10-143: Units Sold by Region, LDR Brachytherapy Iodine Seed Market, Global, 2021 - 2031
- Figure 10-144: Average Selling Price by Region, LDR Brachytherapy Iodine Seed Market, Global, 2021 - 2031 (US$)
- Figure 10-145: Market Value by Region, LDR Brachytherapy Iodine Seed Market, Global, 2021 - 2031 (US$M)
- Figure 10-146: Leading Competitors, Low-Dose Radiation Brachytherapy Market, Global, 2024
The global low-dose radiation brachytherapy (LDRB) market was valued at $102 million in 2024 and is expected to grow at a CAGR of 2.2%, reaching $119 million by 2031.
Market Segments Covered:
- LDR Needles
- LDR Brachytherapy Iodine-125 Seeds
Comprehensive Market Insights
- Market Size & Growth Trends
- Unit Sales & Average Selling Prices
- Market Drivers & Limiters
- Procedure Numbers
- Forecasts Until 2031 & Historical Data (2021-2023)
- Competitive Market Share Insights
- Recent Mergers & Acquisitions
- Company Profiles & Product Portfolios
Global Low-Dose Radiation Brachytherapy Market Trends
- Stable Market Growth: Research on the effectiveness of brachytherapy versus external beam radiotherapy (EBRT) continues, leading to a stable demand for LDRB solutions.
- Expanded Use of Iodine-125 Seeds: Used for various tumor types, including prostate, lung, pancreatic, and head & neck cancers.
- Technology Advancements: Improvements in fluoroscopy and ultrasound imaging enhance precision in needle placement for better clinical outcomes.
Market Share Insights
Top Competitors in the Global LDRB Market (2024):
1 Becton Dickinson (BD)
* Market leader with a strong presence due to its BrachySource(R) iodine seeds.
2 Theragenics
* Specializes in LDRB seeds (iodine & palladium) and LDRB needles.
* BXTAccelyon is its European distributor.
3 Eckert & Ziegler BEBIG
* Offers the IsoSeed(R) line of brachytherapy seeds.
Market Segmentation Summary
- LDR Needles
- LDR Brachytherapy Iodine-125 Seeds
Global Research Scope
Report Details:
- Regions Covered:
* North America: U.S., Canada
* Latin America: Brazil, Mexico, Argentina, etc.
* Western Europe: U.K., Germany, France, Spain, Italy, etc.
* Central & Eastern Europe: Russia, Poland, Turkey, etc.
* Middle East: Saudi Arabia, UAE, Israel, etc.
* Asia Pacific: China, Japan, India, Australia, etc.
* Africa: South Africa, Nigeria, Egypt, etc.
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage:
- Market Size, Market Shares, Market Growth Rates
- Unit Sales & Average Selling Prices
Qualitative Coverage:
- COVID-19 Impact
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls & Disruptive Technologies
- Disease Overviews
Data Sources:
- Industry Leader Interviews
- Government & Regulatory Data
- Hospital & Private Sector Data
- Import & Export Records
- iData Research Internal Database
TABLE OF CONTENT
Table of Contents
Low-Dose Radiation Brachytherapy Market
- 10.1 Executive Summary
- 10.1.1 Global Low-Dose Radiation Brachytherapy Market Overview
- 10.1.2 Competitive Analysis
- 10.1.3 Market Segmentation
- 10.1.4 Regions Included
- 10.2 Introduction
- 10.3 Prostate Cancer Treatment Procedure Numbers
- 10.3.1 Open Prostatectomy Procedures
- 10.3.2 Laparoscopic Prostatectomy Procedures
- 10.3.3 Robotic Prostatectomy Procedures
- 10.3.4 Watchful Waiting Procedures
- 10.3.5 HIFU Procedures
- 10.3.6 Brachytherapy Procedures
- 10.3.7 High-Dose Radiation Procedures
- 10.3.8 External Radiation Therapy (Primary) Procedures
- 10.3.9 External Radiation Therapy (Secondary) Procedures
- 10.4 Market Analysis and Forecast
- 10.4.1 LDR Needle Market
- 10.4.2 LDR Brachytherapy Iodine Seed Market
- 10.5 Drivers and Limiters
- 10.5.1 Market Drivers
- 10.5.2 Market Limiters
- 10.6 Competitive Market Share Analysis


